Daratumumab in HLA Desensitization Prior to Transplantation
Daratumumab in HLA Desensitization Prior to Transplantation
Enrolling by invitation · NCT05300451 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Daratumumab in HLA Desensitization Prior to Transplantation | Cardiac Transplant | Enrolling by invitation | Phase 2 | 2026-10-09 | NCT05300451 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Barry A. Boilson | 1 |
| Janssen Biotech, Inc. | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Rochester | Rochester | United States | 133 |